The marcus evans 5th Product and Pipeline Enhancement for Generics Conference will host industry leaders within the Generic Pharmaceutical, Branded Pharmaceutical and API industries operating globally as they share best practices, strategies and tools on portfolio management and business strategy, as well as legal, intellectual property and patent issues.
Attendees will leave this conference with a better understanding of:
1. Current and upcoming FDA proposals and regulations to ensure compliance
2. Innovation in the drug pipeline
3. Portfolio management and business development
4. How to protect the companyâ€™s patentsâ€™ and intellectual property
5. Expanding the commercial reach through biosimilars
6. Market changes and future industry developments
Current speakers include Harvest Moon Pharmaceuticals, Glenmark Pharmaceuticals, Amneal Pharmaceuticals, Federal Trade Commission, Sandoz Inc., Impax Laboratories, Inc., Hospira, CorePharma LLC and many more!
With a one-track focus, the 5
Contact Show Management for Exact Location
VPâ€™s, Directors and Managers in: